Abstract
beta-Amyloid precursor protein apparently undergoes at least three major cleavages, gamma-, epsilon-, and the newly identified zeta-cleavage, within its transmembrane domain to produce secreted beta-amyloid protein (Abeta). However, the roles of epsilon- and zeta-cleavages in the formation of secreted Abeta and the relationship among these three cleavages, namely epsilon-, zeta-, and gamma-cleavages, remain elusive. We investigated these issues by attempting to determine the formation and turnover of the intermediate products generated by these cleavages, in the presence or absence of known gamma-secretase inhibitors. By using a differential inhibition strategy, our data demonstrate that Abeta(46) is an intermediate precursor of secreted Abeta. Our co-immunoprecipitation data also reveal that, as an intermediate, Abeta(46) is tightly associated with presenilin in intact cells. Furthermore, we identified a long Abeta species that is most likely the long sought after intermediate product, Abeta(49), generated by epsilon-cleavage, and this Abeta(49) is further processed by zeta- and gamma-cleavages to generate Abeta(46) and ultimately the secreted Abeta(40/42). More interestingly, our data demonstrate that gamma-cleavage not only occurs last but also depends on zeta-cleavage occurring prior to it, indicating that zeta-cleavage is crucial for the formation of secreted Abeta. Thus, we conclude that the C terminus of secreted Abeta is most likely generated by a series of sequential cleavages, namely first epsilon-cleavage which is then followed by zeta- and gamma-cleavages, and that Abeta(46) produced by zeta-cleavage is the precursor of secreted Abeta(40/42).
Highlights
In understanding the mechanism by which the C termini of secreted A are generated during the processing of APP, three major intramembranous cleavages have been established
L-685,458 Inhibits the Formation of amyloid protein (A)46—In our recent study, we have shown that treatment of cells with nontransition state ␥-secretase inhibitors, such as DAPT, DAPM, and compound E, caused an increase in the accumulation of intracellular A46, indicating that these inhibitors have no effect, or little effect, on the newly identified -cleavage
It cannot be ruled out that the absence of A46 in cells treated with L-685,458 may be due to the inability of this inhibitor to block the turnover of A46
Summary
In understanding the mechanism by which the C termini of secreted A are generated during the processing of APP, three major intramembranous cleavages have been established. The second one is the ⑀-cleavage occurring between A residues 49 and 50, which produces the N terminus of most of the APP intracellular domain (AICD) [5,6,7,8] The identification of this ⑀-cleavage site raises a question as to whether this ⑀-cleavage is obligatory for the generation of the C terminus of A, and this raises a question as to the relationship between ⑀- and ␥-cleavages, i.e. whether they are independent of each other or sequential. After centrifugation at 20,000 ϫ g at 4 °C for 15 min, the supernatant was diluted with an equal amount of IP buffer, and the A49 and other intracellular A species were immunoprecipitated using 6E10 in the presence or absence of DAPT. DAPM was used to cause the accumulation of A46 in cells that would be used for determining the turnover of A46 either in intact cells or in a cell-free system in which the inhibitor used for causing the accumulation of A46 needs to be removed
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have